Skip to main content

Shoulder Disease

0
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Nordic Pharma
Nordic PharmaFrance - Paris
1 program
Systematic use of patient reported outcome measures in clinical work with the patientsN/A1 trial
Active Trials
NCT06435494Enrolling By Invitation1,000Est. Sep 2030
Integra LifeSciences
Integra LifeSciencesAustralia - Clayton
1 program
Titan Modular Total Shoulder SystemN/A1 trial
Active Trials
NCT03956316Completed25Est. Dec 2015
Connect Biopharma
Connect BiopharmaSAN DIEGO, CA
1 program
Use of VirtuaCare™ for home programN/A1 trial
Active Trials
NCT06016257Recruiting20Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Nordic PharmaSystematic use of patient reported outcome measures in clinical work with the patients
Connect BiopharmaUse of VirtuaCare™ for home program
Integra LifeSciencesTitan Modular Total Shoulder System

Clinical Trials (3)

Total enrollment: 1,045 patients across 3 trials

NCT06435494Nordic PharmaSystematic use of patient reported outcome measures in clinical work with the patients

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions

Start: Aug 2024Est. completion: Sep 20301,000 patients
N/AEnrolling By Invitation
NCT06016257Connect BiopharmaUse of VirtuaCare™ for home program

Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study

Start: Feb 2024Est. completion: Dec 202620 patients
N/ARecruiting
NCT03956316Integra LifeSciencesTitan Modular Total Shoulder System

Short-Term Outcomes of Total Shoulder Arthroplasty Using the Titan Modular Total Shoulder System

Start: Oct 2014Est. completion: Dec 201525 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 1,045 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.